GlassScriptPhysician profile
Elizabeth Klimowicz
NPI 1235579129
$872.36
in general payments reported to CMS, 2019-2025
20 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.70 · 2021: $22.85 · 2022: $102 · 2023: $65.21 · 2024: $253 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $693.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $167.27 | 2024-2025 | Zurzuvae |
| Exeltis, USA INC. | $89.79 | 2021-2025 | Slynd |
| Hologic Sales and Service, LLC | $74.34 | 2022-2025 | Aptima |
| Shield Therapeutics INC | $69.33 | 2024 | |
| Mayne Pharma Commercial LLC | $62.20 | 2022-2025 | |
| Abbvie INC. | $60.97 | 2019-2024 | |
| Supernus Pharmaceuticals, INC. | $42.68 | 2025 | Qelbree |
| Organon LLC | $38.34 | 2023 | Nexplanon |
| Evofem Biosciences, INC. | $37.19 | 2024-2025 | Solosec, Phexx, Phexxi |
| Sumitomo Pharma America, INC. | $34.83 | 2024-2025 | Myfembree |
| Astellas Pharma US INC | $28.87 | 2024 | Veozah |
| Caldera Medical, INC | $26.87 | 2023 | Desara |
| Avion Pharmaceuticals | $26.70 | 2019-2021 | |
| Coopersurgical, INC. | $24.37 | 2025 | Paragard T 380a |
| Bayer Healthcare Pharmaceuticals INC. | $17.17 | 2024 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Millicent US INC | $16.99 | 2025 | Intrarosa |
| Therapeuticsmd, INC. | $15.00 | 2022 | |
| Pfizer INC. | $13.87 | 2022 | |
| Amgen INC. | $13.57 | 2019 | |
| Minerva Surgical, INC | $12.01 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Klimowicz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.